Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

Recruiting now · Phase 2

Conditions studied: Tinea Pedis

In brief

This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).

Key facts

Study ID

NCT07245667

Run by

Propedix, Inc.

People needed

150

Starts

2024-12-30

Expected to finish

2026-02-01

Last updated by the study team

2025-11-28

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female, aged 16 or above
• Clinical diagnosis of tinea pedis (For Cohort 4, positive symptomology is acceptable)
• Confirmation of diagnosis with positive potassium hydroxide (KOH) microscopy (For Cohort 4, a negative KOH test is acceptable)
• Signed and dated informed consent form
• Willingness to comply with study protocol and availability for the duration of the study

You may not qualify if…

• Diagnosis of moccasin-type tinea pedis
• Presence of serous exudate or pus
• Treatment with a topical antifungal in the past 2 weeks
• Treatment with a systemic antifungal in the past 4 weeks
• Concurrent immunosuppressive or antimicrobial therapy
• Liver disease
• Pregnancy or breastfeeding
• Use any other antifungal therapy during trial or within three months of starting the trial
• Known hypersensitivity to any ingredients of trial agents
• Patients with a current diagnosis of diabetes or neuropathy

Where it is running

• Kuchnir Dermatology and Dermatological Surgery — Framingham, Massachusetts, United States (enrolling)
• Kuchnir Dermatology and Dermatological Surgery — Milford, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.